Commercial positioning
Built for research intelligence, not patient care.
Repositioning Intelligence is intended for qualified professionals in pharma, biotech, academia, investment, and translational research. It provides decision support and hypothesis generation—it is not a diagnostic or treatment tool.
Portfolio intelligence for established pharmaceutical organizations.
Prioritize repurposing candidates across your marketed portfolio, identify lifecycle extension opportunities, and triage external assets with evidence-graded confidence scores.
BiotechDe-risk indication expansion for clinical-stage biotech.
Validate repositioning hypotheses before committing scarce clinical resources. Our evidence grading separates strong signals from speculative claims.
AcademiaHypothesis generation for translational researchers.
Access curated drug–disease evidence with full PubMed and ClinicalTrials.gov citations for grant proposals, systematic reviews, and collaborative discovery.
InvestorsDue diligence intelligence for life sciences investors.
Evaluate repurposing narratives with graded evidence rather than press releases. Confidence scores and negative results (e.g., hydroxychloroquine–COVID-19) build trust.
ResearchersDecision support for bench-to-bedside investigators.
Explore drug, disease, and target relationships with authoritative sources. This platform is research intelligence—not a diagnostic or treatment tool.